Dr. Khalid Raza, an associate professor at Jamia Millia Islamia, has been awarded a significant research grant of approximately Rs 94 lakh from the Indian Council of Medical Research (ICMR) to advance his work on artificial intelligence in breast cancer treatment.

This three-year grant will facilitate advanced experimentation and promote collaboration with leading experts in the field, aiming to accelerate the development of innovative solutions for breast cancer.

The funding will support the creation of AI-guided tools for drug design, focusing on optimizing drug compounds, identifying therapeutic targets, and exploring novel treatment strategies specifically for breast cancer.

This initiative reflects the growing role of artificial intelligence in healthcare and aligns with India's broader efforts to leverage technology for medical advancements.

The research is expected to address critical challenges in breast cancer treatment, potentially leading to transformative outcomes in global healthcare practices.

Integrating AI into drug research is believed to streamline development processes, reduce costs, and improve treatment specificity for complex diseases like cancer.

A key component of this research involves further exploration of Raza's patented drug compound, 'DdpMPyPEPhU,' which will be investigated under this initiative.

Raza specializes in applying AI in healthcare, particularly in drug design optimization through AI-based multitarget docking, molecular simulations, and genomics-driven personalized medicine.

Recognized for his contributions, Dr. Raza has authored over 140 research articles and has been acknowledged as one of the top 2% of scientists globally by Stanford University for three consecutive years.

Expressing gratitude for the grant, Raza emphasized its potential to enhance AI-driven drug design and improve health outcomes for millions, while also acknowledging the support of his research team and ICMR.

Jamia Millia Islamia's Vice-Chancellor and Registrar praised Raza's achievement, highlighting the university's commitment to research excellence and innovation in healthcare.